Dr. Collins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2661- Is this information wrong?
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
- Baylor University Medical CenterResidency, Internal Medicine, 1984 - 1987
- University of Missouri Kansas City School of MedicineClass of 1984
Certifications & Licensure
- TX State Medical License 1986 - 2024
- CA State Medical License 1987 - 2024
- OK State Medical License 1985 - 1986
- AL State Medical License Active through 1965
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine Start of enrollment: 2013 Aug 01
- Allograft for Sickle Cell Disease and Thalassemia Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.Mohammad Faizan Zahid, Kelsey Moriarty, Courtney Dryden, Olga Weinberg, Misha Asif, Ruth Ikpefan, Julia M Anderson, Robert H Collins, Stephen S Chung, Weina Chen, Prap...> ;European Journal of Haematology. 2023 Dec 1
- Serum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predictmutation in acute myeloid leukemia.Chelsea Zhang, Andrew Chu, Richard Boriack, Robert Collins, Jing Xu, Dwight Oliver, Ruifang Zheng, Dinesh Rakheja, Weina Chen> ;Ejhaem. 2023 Aug 1
- Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience.Fieke W Hoff, Stephen S Chung, Prapti A Patel, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Selamawit Yohannes, Jaime Shahan, He...> ;Transplant Immunology. 2023 Apr 1
- Join now to see all
Journal Articles
- LILRB4 Signalling in Leukaemia Cells Mediates T Cell Suppression and Tumour InfiltrationNam Nguyen, Robert Collins, Hong Zhu, Nisha Unni, Benjamin Chen, Jaehyup Kim, Nature
Abstracts/Posters
- Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable RemissionsRobert H. Collins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant AbstractRobert H. Collins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Remembering Dr. Eugene P. Frenkel, Who Led Division of Hematology and Oncology for 30 Years at UT SouthwesternJune 23rd, 2019
- Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
Hospital Affiliations
- University of Texas Southwestern Medical CenterDallas, Texas
- Children's Medical Center DallasDallas, Texas
- William P. Clements, Jr. University HospitalDallas, Texas
- Dallas Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: